The Atlas Arteria Group (ASX: ALX) share price is in focus today after the company unveiled its 2025 fullâyear results, which saw a 9.4% lift in proportional toll revenue and a reaffirmed distribution guidance.
What did Atlas Arteria report?
- Proportional toll revenue grew 9.4% to $2,012.3 million
- Proportional EBITDA increased 9.3% to $1,509.9 million, with a 75.0% margin
- Statutory net profit after tax was $181.8 million, impacted by the Temporary Supplemental Tax
- Operating free cash flow per security came in at 34.9 cents
- Distribution paid and guidance for 2025 are both 40.0 cents per security
What else do investors need to know?
Atlas Arteria implemented a new leadership structure during 2025, sharpening its focus on strategic priorities. The company refreshed its executive team, appointing new CEOs at Dulles Greenway and Chicago Skyway to drive results and strategic execution.
Operationally, traffic performance was steady across the portfolio, with Dulles Greenway seeing an 8.2% increase in volume as drivers avoided congestion on alternate routes. The company also submitted a new rate case application for Dulles Greenway in December and continues to pursue growth projects in France, particularly with the A412 motorway.
What did Atlas Arteria management say?
CEO Hugh Wehby said:
2025 was another positive year for Atlas Arteria. We delivered strong revenue growth and steady traffic performance. We continued to build and optimise our businesses to improve safety and customer experience. This performance supports a 40 cps distribution for our investors for 2025, in line with guidance.
What’s next for Atlas Arteria?
Looking ahead, Atlas Arteria reaffirmed its distribution guidance of 40.0 cents per security for both 2025 and 2026, with plans to maintain or exceed this level subject to ongoing business performance. The company highlighted continued growth in free cash flow and an FX hedging program to help support distributions.
Atlas Arteria remains committed to building a resilient, long-term portfolio. Its strategy focuses on optimising current operations, seeking value-accretive growth opportunities, and preparing for French concession retenders in the coming decade.
Atlas Arteria share price snapshot
Over the past 12 months, Atlas Arteria shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 11% over the same period.
The post Atlas Arteria results: 2025 toll revenue climbs, 40c distribution on track appeared first on The Motley Fool Australia.
Should you invest $1,000 in Atlas Arteria Limited right now?
Before you buy Atlas Arteria Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Atlas Arteria Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- DroneShield wins $21.7m in western military contracts
- Sigma Healthcare shares: 1H26 profit and sales leap
- Qantas earnings: Profit up, higher dividends, and bigger fleet for FY26
- Westgold Resources posts record profit and revenue for H1 FY26
- Vault Minerals posts half-year earnings; declares maiden dividend
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.